These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 19050285

  • 21. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.
    Baeyens A, Saadoun D, Billiard F, Rouers A, Grégoire S, Zaragoza B, Grinberg-Bleyer Y, Marodon G, Piaggio E, Salomon BL.
    J Immunol; 2015 Feb 01; 194(3):999-1010. PubMed ID: 25548233
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
    Dawicki W, Bertram EM, Sharpe AH, Watts TH.
    J Immunol; 2004 Nov 15; 173(10):5944-51. PubMed ID: 15528328
    [Abstract] [Full Text] [Related]

  • 24. Contribution of regulatory T cells to alleviation of experimental allergic asthma after specific immunotherapy.
    Maazi H, Shirinbak S, Willart M, Hammad HM, Cabanski M, Boon L, Ganesh V, Baru AM, Hansen G, Lambrecht BN, Sparwasser T, Nawijn MC, van Oosterhout AJ.
    Clin Exp Allergy; 2012 Oct 15; 42(10):1519-28. PubMed ID: 22994349
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
    Turnquist HR, Raimondi G, Zahorchak AF, Fischer RT, Wang Z, Thomson AW.
    J Immunol; 2007 Jun 01; 178(11):7018-31. PubMed ID: 17513751
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells.
    Su W, Zhong W, Zhang Y, Xia Z.
    BMC Immunol; 2012 Jul 06; 13():34. PubMed ID: 22769043
    [Abstract] [Full Text] [Related]

  • 32. Restricted aeroallergen access to airway mucosal dendritic cells in vivo limits allergen-specific CD4+ T cell proliferation during the induction of inhalation tolerance.
    Fear VS, Burchell JT, Lai SP, Wikstrom ME, Blank F, von Garnier C, Turner DJ, Sly PD, Holt PG, Strickland DS, Stumbles PA.
    J Immunol; 2011 Nov 01; 187(9):4561-70. PubMed ID: 21930961
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ, Reome JB, Hollenbaugh JA, Dutton RW.
    J Immunol; 2004 Feb 01; 172(3):1380-90. PubMed ID: 14734713
    [Abstract] [Full Text] [Related]

  • 36. Modulation of regulatory T cells by intranasal allergen immunotherapy in an experimental rat model of airway allergy.
    Moitra S, Datta A, Mondal S, Hazra I, Faruk SMO, Das PK, Basu AK, Tripathi SK, Chaudhuri S.
    Int Immunopharmacol; 2017 Jun 01; 47():9-19. PubMed ID: 28349869
    [Abstract] [Full Text] [Related]

  • 37. Bystander immunotherapy as a strategy to control allergen-driven airway inflammation.
    Navarro S, Lazzari A, Kanda A, Fleury S, Dombrowicz D, Glaichenhaus N, Julia V.
    Mucosal Immunol; 2015 Jul 01; 8(4):841-51. PubMed ID: 25425267
    [Abstract] [Full Text] [Related]

  • 38. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation.
    Kumar P, Marinelarena A, Raghunathan D, Ragothaman VK, Saini S, Bhattacharya P, Fan J, Epstein AL, Maker AV, Prabhakar BS.
    Cell Mol Immunol; 2019 Feb 01; 16(2):138-153. PubMed ID: 29578532
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
    Kitamura N, Murata S, Ueki T, Mekata E, Reilly RT, Jaffee EM, Tani T.
    Int J Cancer; 2009 Aug 01; 125(3):630-8. PubMed ID: 19455675
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.